Global Market Study on Rheumatoid Arthritis Treatment

Published - March 2018| Code - PMR769A| Affiliate - Persistence Market Research

Report Highlights

Global Healthcare Sector Outlook

Despite the economic and political uncertainty in the recent past, the global healthcare industry has been receiving positive nudges from reformative and technological disruptions in medical devices, pharmaceuticals and biotech, in-vitro diagnostics, and medical imaging. Key markets across the world are facing a massive rise in demand for critical care services that are pushing global healthcare spending levels to unimaginable limits.

A rapidly multiplying geriatric population; increasing prevalence of chronic ailments such as cancer and cardiac disease; growing awareness among patients; and heavy investments in clinical innovation are just some of the factors that are impacting the performance of the global healthcare industry. Proactive measures such as healthcare cost containment, primary care delivery, innovation in medical procedures (3-D printing, blockchain, and robotic surgery to name a few), safe and effective drug delivery, and well-defined healthcare regulatory compliance models are targeted at placing the sector on a high growth trajectory across key regional markets.

Parent Indicators Healthcare

Current expenditure on health, % of gross domestic product
Current expenditure on health, per capita, US$ purchasing power parities (current prices, current PPPs)
Annual growth rate of current expenditure on health, per capita, in real terms
Out-of-pocket expenditure, % of current expenditure on health
Out-of-pocket expenditure, per capita, US$ purchasing power parity (current prices, current PPPs)
Physicians, Density per 1000 population (head counts)
Nurses, Density per 1000 population (head counts)
Total hospital beds, per 1000 population
Curative (acute) care beds, per 1000 population
Medical technology, Magnetic Resonance Imaging units, total, per million population
Medical technology, Computed Tomography scanners, total, per million population
Research Methodology

PMR utilizes a triangulation methodology that is primarily based on experimental techniques such as patient-level data, to obtain precise market estimations and insights on Molecule and Drug Classes, API Formulations and preferred modes of administration. Bottom-up approach is always used to obtain insightful data for the specific regions. The country specific data is again analysed to derive data at a global level. This methodology ensures high quality and accuracy of information.

Secondary research is used at the initial phase to identify the age specific disease epidemiology, diagnosis rate and treatment pattern, as per disease indications. Each piece of information is eventually analysed during the entire research project which builds a strong base for the primary research information.

Primary research participants include demand-side users such as key opinion leaders, physicians, surgeons, nursing managers, clinical specialists who provide valuable insights on trends and clinical application of the drugs, key treatment patterns, adoption rate, and compliance rate.

Quantitative and qualitative assessment of basic factors driving demand, economic factors/cycles and growth rates and strategies utilized by key players in the market is analysed in detail while forecasting, in order to project Year-on-Year growth rates. These Y-o-Y growth projections are checked and aligned as per industry/product lifecycle and further utilized to develop market numbers at a holistic level.

On the other hand, we also analyse various companies annual reports, investor presentations, SEC filings, 10k reports and press release operating in this market segment to fetch substantial information about the market size, trends, opportunity, drivers, restraints and to analyse key players and their market shares. Key companies are segmented at Tier level based on their revenues, product portfolio and presence.

Please note that these are the partial steps that are being followed while developing the market size. Besides this, forecasting will be done based on our internal proprietary model which also uses different macro-economic factors such as per capita healthcare expenditure, disposable income, industry based demand driving factors impacting the market and its forecast trends apart from disease related factors.

Key Questions Answered

How the market has performed over the past few years?
What have been the challenges for market participants and how did they overcome them?
How has the technology landscape evolved over the past years?
How the competitors have performed and what have been their growth strategies?
What is the market potential expected to look like in near future across the globe?
How to sustain and grow market share?
What should be the future course of action?
Where do I currently stand?
Which are the segments, factors, regions offering promising growth potential?
What are the trends in the market and am I ready for them?
Market Taxonomy

By Region

North America
Latin America
Europe
Asia Pacific (APAC)
Middle East and Africa (MEA)
By Therapy Type

Symptomatic Treatment
Intermediate Corticosteroid Therapies
Disease Modifying Antirheumatic Drug (DMARD) Therapies
Conventional DMARDs
Biologic DMARDs
By Distribution Channel

Hospital Pharmacy
Retail Pharmacy
Drug Stores

  • Table 1 : Rheumatoid Arthritis Treatment with Conventional DMARDs
  • Table 2 : Types of Biologic DMARDs Covered in the Report
  • Table 3 : Biologic treatment regime for Rheumatoid Arthritis
  • Table 4 : List of Biosimilars to Blockbuster Disease Modifying Anti-rheumatic Drugs (2017)
  • Table 5 : Biologics Net Price Inflation and Value (2016)
  • Table 6 A : Rheumatoid Arthritis Treatment Market Pipeline Analysis (2017)
  • Table 6 B : Rheumatoid Arthritis Treatment Market Pipeline Analysis (2017)
  • Table 6 C : Rheumatoid Arthritis Treatment Market Pipeline Analysis (2017)
  • Table 6 D : Rheumatoid Arthritis Treatment Market Pipeline Analysis (2017)
  • Table 6 E : Rheumatoid Arthritis Treatment Market Pipeline Analysis (2017)
  • Table 6 F : Rheumatoid Arthritis Treatment Market Pipeline Analysis (2017)
  • Table 6 G : Rheumatoid Arthritis Treatment Market Pipeline Analysis (2017)
  • Table 6 H : Rheumatoid Arthritis Treatment Market Pipeline Analysis (2017)
  • Table 6 I : Rheumatoid Arthritis Treatment Market Pipeline Analysis (2017)
  • Table 6 J : Rheumatoid Arthritis Treatment Market Pipeline Analysis (2017)
  • Table 6 K : Rheumatoid Arthritis Treatment Market Pipeline Analysis (2017)
  • Table 6 L : Rheumatoid Arthritis Treatment Market Pipeline Analysis (2017)
  • Table 7 : North America Rheumatoid Arthritis Treatment Market Size Analysis (US$ Mn) Analysis 2012-2016 and Forecast 2017-2025, By Country
  • Table 8 : North America Rheumatoid Arthritis Treatment Market Size Analysis (US$ Mn) Analysis 2012-2016 and Forecast 2017-2025, By Treatment
  • Table 9 : North America Rheumatoid Arthritis Treatment Market Size Analysis (US$ Mn) Analysis 2012-2016 and Forecast 2017-2025, By Distribution Channel
  • Table 10 : Latin America Rheumatoid Arthritis Treatment Market Size Analysis (US$ Mn) Analysis 2012-2016 and Forecast 2017-2025, By Country
  • Table 11 : Latin America Rheumatoid Arthritis Treatment Market Size Analysis (US$ Mn) Analysis 2012-2016 and Forecast 2017-2025, By Treatment
  • Table 12 : Latin America Rheumatoid Arthritis Treatment Market Size Analysis (US$ Mn) Analysis 2012-2016 and Forecast 2017-2025, By Distribution Channel
  • Table 13 : Europe Rheumatoid Arthritis Treatment Market Size Analysis (US$ Mn) Analysis 2012-2016 and Forecast 2017-2025, By Country
  • Table 14 : Europe Rheumatoid Arthritis Treatment Market Size Analysis (US$ Mn) Analysis 2012-2016 and Forecast 2017-2025, By Treatment
  • Table 15 : Europe Rheumatoid Arthritis Treatment Market Size Analysis (US$ Mn) Analysis 2012-2016 and Forecast 2017-2025, By Distribution Channel
  • Table 16 : Asia Pacific Rheumatoid Arthritis Treatment Market Size Analysis (US$ Mn) Analysis 2012-2016 and Forecast 2017-2025, By Country
  • Table 17 : Asia Pacific Rheumatoid Arthritis Treatment Market Size Analysis (US$ Mn) Analysis 2012-2016 and Forecast 2017-2025, By Treatment
  • Table 18 : Asia Pacific Rheumatoid Arthritis Treatment Market Size Analysis (US$ Mn) Analysis 2012-2016 and Forecast 2017-2025, By Distribution Channel
  • Table 19 : MEA Rheumatoid Arthritis Treatment Market Size Analysis (US$ Mn) Analysis 2012-2016 and Forecast 2017-2025, By Country
  • Table 20 : MEA Rheumatoid Arthritis Treatment Market Size Analysis (US$ Mn) Analysis 2012-2016 and Forecast 2017-2025, By Treatment
  • Table 21 : MEA Rheumatoid Arthritis Treatment Market Size Analysis (US$ Mn) Analysis 2012-2016 and Forecast 2017-2025, By Distribution Channel
  • Table 22 : Global Rheumatoid Arthritis Treatment Market Size (US$ Mn) 2012�2016 and Forecast 2017-2025 By Region
  • Table 23 : Global Rheumatoid Arthritis Treatment Market Size Analysis (US$ Mn) Analysis 2012-2016 and Forecast 2017-2025, By Treatment
  • Table 24 : Global Rheumatoid Arthritis Treatment Market Size Analysis (US$ Mn) Analysis 2012-2016 and Forecast 2017-2025, By Distribution Channel
  • Figure 1 : Global Rheumatoid Arthritis Treatment Market Split By treatment, 2017E
  • Figure 2 : Global Rheumatoid Arthritis Treatment Market Split By DMARD Therapies, 2017E
  • Figure 3 : Global Rheumatoid Arthritis Treatment Market Split By Distribution Channel, 2017E
  • Figure 4 : Wheel of Fortune
  • Figure 5 : Stages of Rheumatoid Arthritis
  • Figure 6 : Biologics DMARDs Acting At Different Stages Of Inflammatory Pathway In Rheumatoid Arthritis
  • Figure 7 : Distribution of Causes of Disabilities in the U.S. (2015)
  • Figure 8 : Average Annual Treatment Cost of Biologic Treatment for RA (2016)
  • Figure 9 : Distribution of Symptoms Experience by Rheumatoid Arthritis Patients in the U.K.
  • Figure 10 : Proportion of Patients Needed to Discontinue the Biologic Therapy due to Adverse Reactions
  • Figure 11 : Common Diseases Treated with Regenerative Therapy and share of Rheumatoid Arthritis in it
  • Figure 12 : Distribution of Regenerative Medicine Clinical Programs by Phase and by Region (2016)
  • Figure 13 : Distribution of Industry Sponsored Clinical Programs for Microbiome Therapeutics, by Phase
  • Figure 14 : Number of Clinical Programs (phase III & phase IV) expected to be completed by 2020, by company
  • Figure 15 : Geographical Distribution of Clinical Trials for Rheumatoid Arthritis (2017)
  • Figure 16 : North America Rheumatoid Arthritis Treatment Market Value Share, By Country (2017)
  • Figure 17 : North America Rheumatoid Arthritis Treatment Market Value Share, By Treatment (2017)
  • Figure 18 : North America Rheumatoid Arthritis Treatment Market Value Share, By Distribution Channel (2017)
  • Figure 19 : North America Rheumatoid Arthritis Treatment Market Value (US$ Mn) 2017E and 2025F
  • Figure 20 : North America Rheumatoid Arthritis Treatment Market Size (US$ Mn) Analysis, 2012�2016
  • Figure 21 : North America Rheumatoid Arthritis Treatment Market Size (US$ Mn) & Y-o-Y Growth (%), 2017�2025
  • Figure 22 : U.S. Rheumatoid Arthritis Treatment Market Size (US$ Mn) Analysis, 2012�2016
  • Figure 23 : U.S. Rheumatoid Arthritis Treatment Market Value (US$ Mn) & Y-o-Y Growth (%), 2017�2025
  • Figure 24 : Canada Rheumatoid Arthritis Treatment Market Size (US$ Mn) Analysis, 2012�2016
  • Figure 25 : Canada Rheumatoid Arthritis Treatment Market Value (US$ Mn) & Y-o-Y Growth (%), 2017�2025
  • Figure 26 : North America Rheumatoid Arthritis Treatment Market Size (US$ Mn) Analysis, 2012�2016, By Symptomatic Treatment
  • Figure 27 : North America Rheumatoid Arthritis Treatment Market Value (US$ Mn) & Y-o-Y Growth (%), 2017�2025, By Symptomatic Treatment
  • Figure 28 : North America Rheumatoid Arthritis Treatment Market Size (US$ Mn) Analysis, 2012�2016, By Intermediate Therapy
  • Figure 29 : North America Rheumatoid Arthritis Treatment Market Value (US$ Mn) & Y-o-Y Growth (%), 2017�2025, By Intermediate Therapy
  • Figure 30 : North America Rheumatoid Arthritis Treatment Market Size (US$ Mn) Analysis, 2012�2016, By DMARD Therapies
  • Figure 31 : North America Rheumatoid Arthritis Treatment Market Value (US$ Mn) & Y-o-Y Growth (%), 2017�2025, By DMARD Therapies
  • Figure 32 : North America Rheumatoid Arthritis Treatment Market Attractiveness Analysis, By Country
  • Figure 33 : North America Rheumatoid Arthritis Treatment Market Attractiveness Analysis, By Treatment
  • Figure 34 : North America Rheumatoid Arthritis Treatment Market Attractiveness Analysis, By DMARD Therapies
  • Figure 35 : North America Rheumatoid Arthritis Treatment Market Attractiveness Analysis, By Distribution Channel
  • Figure 36 : Latin America Rheumatoid Arthritis Treatment Market Value Share, By Country (2017)
  • Figure 37 : Latin America Rheumatoid Arthritis Treatment Market Value Share, By Treatment (2017)
  • Figure 38 : Latin America Rheumatoid Arthritis Treatment Market Value Share, By Distribution Channel (2017)
  • Figure 39 : Latin America Rheumatoid Arthritis Treatment Market Value (US$ Mn) 2017E and 2025F
  • Figure 40 : Latin America Rheumatoid Arthritis Treatment Market Size (US$ Mn) Analysis, 2012�2016
  • Figure 41 : Latin America Rheumatoid Arthritis Treatment Market Size (US$ Mn) & Y-o-Y Growth (%), 2017�2025
  • Figure 42 : Brazil Rheumatoid Arthritis Treatment Market Size (US$ Mn) Analysis, 2012�2016
  • Figure 43 : Brazil Rheumatoid Arthritis Treatment Market Value (US$ Mn) & Y-o-Y Growth (%), 2017�2025
  • Figure 44 : Mexico Rheumatoid Arthritis Treatment Market Size (US$ Mn) Analysis, 2012�2016
  • Figure 45 : Mexico Rheumatoid Arthritis Treatment Market Value (US$ Mn) & Y-o-Y Growth (%), 2017�2025
  • Figure 46 : Rest of Latin America Rheumatoid Arthritis Treatment Market Size (US$ Mn) Analysis, 2012�2016
  • Figure 47 : Rest of Latin America Rheumatoid Arthritis Treatment Market Value (US$ Mn) & Y-o-Y Growth (%), 2017�2025
  • Figure 48 : Latin America Rheumatoid Arthritis Treatment Market Size (US$ Mn) Analysis, 2012�2016, By Symptomatic Treatment
  • Figure 49 : Latin America Rheumatoid Arthritis Treatment Market Value (US$ Mn) & Y-o-Y Growth (%), 2017�2025, By Symptomatic Treatment
  • Figure 50 : Latin America Rheumatoid Arthritis Treatment Market Size (US$ Mn) Analysis, 2012�2016, By Intermediate Therapy
  • Figure 51 : Latin America Rheumatoid Arthritis Treatment Market Value (US$ Mn) & Y-o-Y Growth (%), 2017�2025, By Intermediate Therapy
  • Figure 52 : Latin America Rheumatoid Arthritis Treatment Market Size (US$ Mn) Analysis, 2012�2016, By DMARD Therapies
  • Figure 53 : Latin America Rheumatoid Arthritis Treatment Market Value (US$ Mn) & Y-o-Y Growth (%), 2017�2025, By DMARD Therapies
  • Figure 54 : Latin America Rheumatoid Arthritis Treatment Market Attractiveness Analysis, By Country
  • Figure 55 : Latin America Rheumatoid Arthritis Treatment Market Attractiveness Analysis, By Treatment
  • Figure 56 : Latin America Rheumatoid Arthritis Treatment Market Attractiveness Analysis, By DMARD Therapies
  • Figure 57 : Latin America Rheumatoid Arthritis Treatment Market Attractiveness Analysis, By Distribution Channel
  • Figure 58 : Europe Rheumatoid Arthritis Treatment Market Value Share, By Country (2017)
  • Figure 59 : Europe Rheumatoid Arthritis Treatment Market Value Share, By Treatment (2017)
  • Figure 60 : Europe Rheumatoid Arthritis Treatment Market Value Share, By Distribution Channel (2017)
  • Figure 61 : Europe Rheumatoid Arthritis Treatment Market Value (US$ Mn) 2017E and 2025F
  • Figure 62 : Europe Rheumatoid Arthritis Treatment Market Size (US$ Mn) Analysis, 2012�2016
  • Figure 63 : Europe Rheumatoid Arthritis Treatment Market Size (US$ Mn) & Y-o-Y Growth (%), 2017�2025
  • Figure 64 : Germany Rheumatoid Arthritis Treatment Market Size (US$ Mn) Analysis, 2012�2016
  • Figure 65 : Germany Rheumatoid Arthritis Treatment Market Value (US$ Mn) & Y-o-Y Growth (%), 2017�2025
  • Figure 66 : Italy Rheumatoid Arthritis Treatment Market Size (US$ Mn) Analysis, 2012�2016
  • Figure 67 : Italy Rheumatoid Arthritis Treatment Market Value (US$ Mn) & Y-o-Y Growth (%), 2017�2025
  • Figure 68 : France Rheumatoid Arthritis Treatment Market Size (US$ Mn) Analysis, 2012�2016
  • Figure 69 : France Rheumatoid Arthritis Treatment Market Value (US$ Mn) & Y-o-Y Growth (%), 2017�2025
  • Figure 70 : U.K. Rheumatoid Arthritis Treatment Market Size (US$ Mn) Analysis, 2012�2016
  • Figure 71 : U.K. Rheumatoid Arthritis Treatment Market Value (US$ Mn) & Y-o-Y Growth (%), 2017�2025
  • Figure 72 : Spain Rheumatoid Arthritis Treatment Market Size (US$ Mn) Analysis, 2012�2016
  • Figure 73 : Spain Rheumatoid Arthritis Treatment Market Value (US$ Mn) & Y-o-Y Growth (%), 2017�2025
  • Figure 74 : Russia Rheumatoid Arthritis Treatment Market Size (US$ Mn) Analysis, 2012�2016
  • Figure 75 : Russia Rheumatoid Arthritis Treatment Market Value (US$ Mn) & Y-o-Y Growth (%), 2017�2025
  • Figure 76 : Rest of Europe Rheumatoid Arthritis Treatment Market Size (US$ Mn) Analysis, 2012�2016
  • Figure 77 : Rest of Europe Rheumatoid Arthritis Treatment Market Value (US$ Mn) & Y-o-Y Growth (%), 2017�2025
  • Figure 78 : Europe Rheumatoid Arthritis Treatment Market Size (US$ Mn) Analysis, 2012�2016, By Symptomatic Treatment
  • Figure 79 : Europe Rheumatoid Arthritis Treatment Market Value (US$ Mn) & Y-o-Y Growth (%), 2017�2025, By Symptomatic Treatment
  • Figure 80 : Europe Rheumatoid Arthritis Treatment Market Size (US$ Mn) Analysis, 2012�2016, By Intermediate Therapy
  • Figure 81 : Europe Rheumatoid Arthritis Treatment Market Value (US$ Mn) & Y-o-Y Growth (%), 2017�2025, By Intermediate Therapy
  • Figure 82 : Europe Rheumatoid Arthritis Treatment Market Size (US$ Mn) Analysis, 2012�2016, By DMARD Therapies
  • Figure 83 : Europe Rheumatoid Arthritis Treatment Market Value (US$ Mn) & Y-o-Y Growth (%), 2017�2025, By DMARD Therapies
  • Figure 84 : Europe Rheumatoid Arthritis Treatment Market Attractiveness Analysis, By Country
  • Figure 85 : Europe Rheumatoid Arthritis Treatment Market Attractiveness Analysis, By Treatment
  • Figure 86 : Europe Rheumatoid Arthritis Treatment Market Attractiveness Analysis, By DMARD Therapies
  • Figure 87 : Europe Rheumatoid Arthritis Treatment Market Attractiveness Analysis, By Distribution Channel
  • Figure 88 : Asia Pacific Rheumatoid Arthritis Treatment Market Value Share, By Country (2017)
  • Figure 89 : Asia Pacific Rheumatoid Arthritis Treatment Market Value Share, By Treatment (2017)
  • Figure 90 : Asia Pacific Rheumatoid Arthritis Treatment Market Value Share, By Distribution Channel (2017)
  • Figure 91 : Asia Pacific Rheumatoid Arthritis Treatment Market Value (US$ Mn) 2017E and 2025F
  • Figure 92 : Asia Pacific Rheumatoid Arthritis Treatment Market Size (US$ Mn) Analysis, 2012�2016
  • Figure 93 : Asia Pacific Rheumatoid Arthritis Treatment Market Size (US$ Mn) & Y-o-Y Growth (%), 2017�2025
  • Figure 94 : Japan Rheumatoid Arthritis Treatment Market Size (US$ Mn) Analysis, 2012�2016
  • Figure 95 : Japan Rheumatoid Arthritis Treatment Market Value (US$ Mn) & Y-o-Y Growth (%), 2017�2025
  • Figure 96 : India Rheumatoid Arthritis Treatment Market Size (US$ Mn) Analysis, 2012�2016
  • Figure 97 : India Rheumatoid Arthritis Treatment Market Value (US$ Mn) & Y-o-Y Growth (%), 2017�2025
  • Figure 98 : China Rheumatoid Arthritis Treatment Market Size (US$ Mn) Analysis, 2012�2016
  • Figure 99 : China Rheumatoid Arthritis Treatment Market Value (US$ Mn) & Y-o-Y Growth (%), 2017�2025
  • Figure 100 : Australia And New Zealand Rheumatoid Arthritis Treatment Market Size (US$ Mn) Analysis, 2012�2016
  • Figure 101 : Australia And New Zealand Rheumatoid Arthritis Treatment Market Value (US$ Mn) & Y-o-Y Growth (%), 2017�2025
  • Figure 102 : ASEAN Rheumatoid Arthritis Treatment Market Size (US$ Mn) Analysis, 2012�2016
  • Figure 103 : ASEAN Rheumatoid Arthritis Treatment Market Value (US$ Mn) & Y-o-Y Growth (%), 2017�2025
  • Figure 104 : Rest of Asia Pacific Rheumatoid Arthritis Treatment Market Size (US$ Mn) Analysis, 2012�2016
  • Figure 105 : Rest of Asia Pacific Rheumatoid Arthritis Treatment Market Value (US$ Mn) & Y-o-Y Growth (%), 2017�2025
  • Figure 106 : Asia Pacific Rheumatoid Arthritis Treatment Market Size (US$ Mn) Analysis, 2012�2016, By Symptomatic Treatment
  • Figure 107 : Asia Pacific Rheumatoid Arthritis Treatment Market Value (US$ Mn) & Y-o-Y Growth (%), 2017�2025, By Symptomatic Treatment
  • Figure 108 : Asia Pacific Rheumatoid Arthritis Treatment Market Size (US$ Mn) Analysis, 2012�2016, By Intermediate Therapy
  • Figure 109 : Asia Pacific Rheumatoid Arthritis Treatment Market Value (US$ Mn) & Y-o-Y Growth (%), 2017�2025, By Intermediate Therapy
  • Figure 110 : Asia Pacific Rheumatoid Arthritis Treatment Market Size (US$ Mn) Analysis, 2012�2016, By DMARD Therapies
  • Figure 111 : Asia Pacific Rheumatoid Arthritis Treatment Market Value (US$ Mn) & Y-o-Y Growth (%), 2017�2025, By DMARD Therapies
  • Figure 112 : Asia Pacific Rheumatoid Arthritis Treatment Market Attractiveness Analysis, By Country
  • Figure 113 : Asia Pacific Rheumatoid Arthritis Treatment Market Attractiveness Analysis, By Treatment
  • Figure 114 : Asia Pacific Rheumatoid Arthritis Treatment Market Attractiveness Analysis, By DMARD Therapies
  • Figure 115 : Asia Pacific Rheumatoid Arthritis Treatment Market Attractiveness Analysis, By Distribution Channel
  • Figure 116 : MEA Rheumatoid Arthritis Treatment Market Value Share, By Country (2017)
  • Figure 117 : MEA Rheumatoid Arthritis Treatment Market Value Share, By Treatment (2017)
  • Figure 118 : MEA Rheumatoid Arthritis Treatment Market Value Share, By Distribution Channel (2017)
  • Figure 119 : MEA Rheumatoid Arthritis Treatment Market Value (US$ Mn) 2017E and 2025F
  • Figure 120 : MEA Rheumatoid Arthritis Treatment Market Size (US$ Mn) Analysis, 2012�2016
  • Figure 121 : MEA Rheumatoid Arthritis Treatment Market Size (US$ Mn) & Y-o-Y Growth (%), 2017�2025
  • Figure 122 : GCC Countries Rheumatoid Arthritis Treatment Market Size (US$ Mn) Analysis, 2012�2016
  • Figure 123 : GCC Countries Rheumatoid Arthritis Treatment Market Value (US$ Mn) & Y-o-Y Growth (%), 2017�2025
  • Figure 124 : South Africa Rheumatoid Arthritis Treatment Market Size (US$ Mn) Analysis, 2012�2016
  • Figure 125 : South Africa Rheumatoid Arthritis Treatment Market Value (US$ Mn) & Y-o-Y Growth (%), 2017�2025
  • Figure 126 : Rest of MEA Rheumatoid Arthritis Treatment Market Size (US$ Mn) Analysis, 2012�2016
  • Figure 127 : Rest of MEA Rheumatoid Arthritis Treatment Market Value (US$ Mn) & Y-o-Y Growth (%), 2017�2025
  • Figure 128 : MEA Rheumatoid Arthritis Treatment Market Size (US$ Mn) Analysis, 2012�2016, By Symptomatic Treatment
  • Figure 129 : MEA Rheumatoid Arthritis Treatment Market Value (US$ Mn) & Y-o-Y Growth (%), 2017�2025, By Symptomatic Treatment
  • Figure 130 : MEA Rheumatoid Arthritis Treatment Market Size (US$ Mn) Analysis, 2012�2016, By Intermediate Therapy
  • Figure 131 : MEA Rheumatoid Arthritis Treatment Market Value (US$ Mn) & Y-o-Y Growth (%), 2017�2025, By Intermediate Therapy
  • Figure 132 : MEA Rheumatoid Arthritis Treatment Market Size (US$ Mn) Analysis, 2012�2016, By DMARD Therapies
  • Figure 133 : MEA Rheumatoid Arthritis Treatment Market Value (US$ Mn) & Y-o-Y Growth (%), 2017�2025, By DMARD Therapies
  • Figure 134 : MEA Rheumatoid Arthritis Treatment Market Attractiveness Analysis, By Country
  • Figure 135 : MEA Rheumatoid Arthritis Treatment Market Attractiveness Analysis, By Treatment
  • Figure 136 : MEA Rheumatoid Arthritis Treatment Market Attractiveness Analysis, By DMARD Therapies
  • Figure 137 : MEA Rheumatoid Arthritis Treatment Market Attractiveness Analysis, By Distribution Channel
  • Figure 138 : Global Rheumatoid Arthritis Industry Structure
  • Figure 139 : Global Rheumatoid Arthritis Treatment Market Share, By Tier (2015)
  • Figure 140 : Global Rheumatoid Arthritis Treatment Market Company Share Analysis (2016)
  • Figure 141 : Global Rheumatoid Arthritis Treatment Market Biologics Brand Share Analysis (2016)
  • Figure 142 : Global Rheumatoid Arthritis Treatment Market Brand Competition Analysis
  • Figure 143 : Percentage of Rheumatologists who Prescribes Xeljanz to over 10% of their Biologic Treated Patients
  • Figure 144 : Frequency for Prescription of Biologics for RA treatment
  • Figure 145 : Level of Satisfaction with Xeljanz for Treatment of RA
  • Figure 146 : Familiarity with Late-Stage JAK Agents in Development
  • Figure 147 : Percentage of Rheumatologists who Prescribes Xeljanz, Olumiant and Kevzara to over 10% of their Biologic Treated Patients
  • Figure 148 : Frequency for Prescription of Biologics for RA treatment
  • Figure 149 : % Prescriptions for Innovator and Biosimilar Biologics for RA Treatment in Europe
  • Figure 150 : Global Rheumatoid Arthritis Treatment Market Share Analysis (%) By Region, 2017 & 2025
  • Figure 151 : Global Rheumatoid Arthritis Treatment Market Y-o-Y Growth (%) By Region, 2016�2025
  • Figure 152 : Global Rheumatoid Arthritis Treatment Market Attractiveness Analysis By Region, 2017�2025
  • Figure 153 : Global Rheumatoid Arthritis Treatment Market Share Analysis (%) By Treatment, 2017 & 2025
  • Figure 154 : Global Rheumatoid Arthritis Treatment Market Y-o-Y Growth (%) By Treatment, 2016�2025
  • Figure 155 : Global Rheumatoid Arthritis Treatment Market Attractiveness Analysis By Treatment, 2017�2025
  • Figure 156 : Global Rheumatoid Arthritis Treatment Market Attractiveness Analysis, By DMARD Therapies
  • Figure 157 : Global Rheumatoid Arthritis Treatment Market Share Analysis (%) By Distribution Channel, 2017 & 2025
  • Figure 158 : Global Rheumatoid Arthritis Treatment Market Y-o-Y Growth (%) By Distribution Channel, 2016�2025
  • Figure 159 : Global Rheumatoid Arthritis Treatment Market Attractiveness Analysis By Distribution Channel, 2017�2025
  • Figure 160 : Global Rheumatoid Arthritis Treatment Market Value Analysis and Forecast, 2016�2025 (US$ Mn)
  • Figure 161 : Global Rheumatoid Arthritis Treatment Market Absolute $ Opportunity (US$ Mn), 2016�2025
  • Figure 162 : Global Rheumatoid Arthritis Treatment Market Value Chain Analysis

Persistence Market Research (PMR) is a third-platform research firm. Our research model is a unique collaboration of data analytics and market research methodology to help businesses achieve optimal performance.

To support companies in overcoming complex business challenges, we follow a multi-disciplinary approach. At PMR, we unite various data streams from multi-dimensional sources. By deploying real-time data collection, big data, and customer experience analytics, we deliver business intelligence for organization of all sizes.

CUSTOM RESEARCH

Need a custom data table, graph or complete report? Tell us more.

Contact Us
Share This Report